Progress in multiple myeloma.
作者信息
Munker Reinhold, Monohan Gregory
机构信息
Department of Internal Medicine, Division of Hematology & BMT, University of Kentucky, Lexington, KY 40536, USA.
出版信息
Indian J Med Res. 2019 Jun;149(6):693-694. doi: 10.4103/ijmr.IJMR_770_19.
Abstract
摘要
相似文献
1
Progress in multiple myeloma.
Indian J Med Res. 2019 Jun;149(6):693-694. doi: 10.4103/ijmr.IJMR_770_19.
2
Multiple myeloma. Progress is being made.
Mayo Clin Health Lett. 2011 Mar;29(3):4-5.
3
Allogeneic stem cell transplantation for multiple myeloma.
Hematol Oncol Clin North Am. 2014 Oct;28(5):891-902. doi: 10.1016/j.hoc.2014.06.001. Epub 2014 Jul 25.
4
Unrelated stem cell transplantation for patients with multiple myeloma.
Curr Opin Hematol. 2010 Nov;17(6):538-43. doi: 10.1097/MOH.0b013e32833e5b01.
5
Multiple myeloma: the role of transplant and novel treatment strategies.
Semin Oncol. 2004 Apr;31(2 Suppl 4):99-105. doi: 10.1053/j.seminoncol.2004.02.015.
6
Frontline therapy for multiple myeloma: a concise review of the evidence based on randomized clinical trials.
Cancer Invest. 2013 Oct;31(8):529-37. doi: 10.3109/07357907.2013.840382.
7
Role of allogeneic stem cell transplantation in multiple myeloma.
Expert Rev Anticancer Ther. 2005 Jun;5(3):455-64. doi: 10.1586/14737140.5.3.455.
8
[Treatment of multiple myeloma].
Bull Cancer. 2006 Jan;93(1):101-6.
9
Cytomegalovirus reactivation after autologous stem cell transplantation in multiple myeloma patients treated with novel agents.
Transpl Infect Dis. 2015 Dec;17(6):931-2. doi: 10.1111/tid.12449. Epub 2015 Nov 5.
10
[Autologous stem cell transplantation in multiple myeloma - contra].
Dtsch Med Wochenschr. 2009 Sep;134(39):1943. doi: 10.1055/s-0029-1237536. Epub 2009 Sep 16.
引用本文的文献
1
Exploring participant perceptions of a virtually supported home exercise program for people with multiple myeloma using a novel eHealth application: a qualitative study.
Support Care Cancer. 2023 Apr 25;31(5):298. doi: 10.1007/s00520-023-07762-y.
2
Feasibility of a tailored and virtually supported home exercise program for people with multiple myeloma using a novel eHealth application.
Digit Health. 2022 Oct 11;8:20552076221129066. doi: 10.1177/20552076221129066. eCollection 2022 Jan-Dec.
3
Identification of metabolic biomarkers to predict treatment outcome and disease progression in multiple myeloma.
Am J Cancer Res. 2020 Nov 1;10(11):3935-3946. eCollection 2020.
本文引用的文献
1
High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma: Predictors of long-term outcome.
Indian J Med Res. 2019 Jun;149(6):730-739. doi: 10.4103/ijmr.IJMR_1593_18.
2
Current status of autologous stem cell transplantation for multiple myeloma.
Blood Cancer J. 2019 Apr 8;9(4):44. doi: 10.1038/s41408-019-0205-9.
3
Daratumumab in multiple myeloma.
Cancer. 2019 Jul 15;125(14):2364-2382. doi: 10.1002/cncr.32065. Epub 2019 Apr 5.
4
Access to hematopoietic stem-cell transplantation in India.
J Postgrad Med. 2019 Jan-Mar;65(1):1-4. doi: 10.4103/jpgm.JPGM_391_18.
5
Pros and cons of frontline autologous transplant in multiple myeloma: the debate over timing.
Blood. 2019 Feb 14;133(7):652-659. doi: 10.1182/blood-2018-08-825349. Epub 2018 Dec 26.
6
Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression.
Nat Commun. 2018 Dec 3;9(1):4832. doi: 10.1038/s41467-018-07305-8.
7
Real‑world multiple myeloma management practice patterns and outcomes in selected Central and Eastern European countries.
Pol Arch Intern Med. 2018 Sep 28;128(9):500-511. doi: 10.20452/pamw.4305. Epub 2018 Jul 27.
8
Allogeneic Stem Cell Transplant for Acute Myeloid Leukemia: Evolution of an Effective Strategy in India.
J Glob Oncol. 2017 Dec;3(6):773-781. doi: 10.1200/JGO.2016.006650. Epub 2017 Feb 8.
9
Multiple myeloma.
Nat Rev Dis Primers. 2017 Jul 20;3:17046. doi: 10.1038/nrdp.2017.46.
10
Allogeneic Hematopoietic Cell Transplantation for Myeloma: When and in Whom Does It Work.
Curr Hematol Malig Rep. 2017 Apr;12(2):126-135. doi: 10.1007/s11899-017-0374-1.
Zotero 插件